Microvolt T-wave alternans testing provides a reliable means of guiding anti-arrhythmic therapy
Author(s)Hohnloser, Stefan H.; Cohen, Richard J.
MetadataShow full item record
Gupta et al1 present a meta-analysis and conclude that microvolt T-wave alternans testing (MTWA) does not modify risk of sudden cardiac death (SCD) sufficiently for clinical use. Their analysis involves a number of methodological limitations. The authors included in their primary analysis numerous surrogates for sudden cardiac death (SCD) such as ICD therapy, cardiac mortality and total mortality.
DepartmentWhitaker College of Health Sciences and Technology; Harvard University--MIT Division of Health Sciences and Technology
American Heart Journal
Hohnloser, Stefan H., and Richard J. Cohen. Microvolt T-wave Alternans Testing Provides a Reliable Means of Guiding Anti-arrhythmic Therapy. American Heart Journal 164, no. 4 (October 2012): e7.
Author's final manuscript